Possible benefit of PRP injections in patients with grade II hamstring tear .
This report has been verified
by one or more authors of the
original publication.
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Platelet-rich plasma injections for the treatment of hamstring injuries: a randomized controlled trial
Am J Sports Med. 2014 Oct;42(10):2410-8.28 patients with a grade II hamstring injury were allocated to undergo daily home-based rehabilitation exercises, and randomized to either receive or not receive an injection of platelet-rich plasma upon presentation to the sports medicine clinic. Participants were followed-up for time to return to play, as well as improvement of pain. Mean time to return to play was 27 days in the PRP group and 42.5 days in the control group, and log-rank test for return to play revealed significantly quicker return to play among the group who received PRP injection compared to those who did not.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
